| Document Date: 2014-04-29 16:03:06
Open Document File Size: 927,11 KBShare Result on Facebook
City Reference / / Company Human Experience / Janssen Pharmaceuticals Inc. / / Event FDA Phase / / IndustryTerm beverage / Treatment of irritability associated with autistic disorder / machinery / / MedicalCondition polyuria / rash / nasal congestion / Dementia / Seizures / Leukopenia / nausea / Autistic Disorder RISPERDAL / Known hypersensitivity / transient ischemic attack / tremor / fatigue / tachycardia / both serious medical illness / diarrhea / Neuroleptic Malignant Syndrome / hypersensitivity / anaphylactic reactions / myoglobinuria / mg Schizophrenia / mg Bipolar mania / heat stroke / Phenylketonuria / constipation / muscle rigidity / Bipolar mania / systemic infection / Agranulocytosis / upper respiratory tract infection / Hyperprolactinemia / Priapism / pneumonia / schizophrenia / parkinsonism / Disease / I Disorder / nasopharyngitis / chronic treatment / Dysphagia / Carcinogenesis / hyperglycemia / chronic / Neutropenia / stroke / dyslipidemia / chronic illness / mania / diabetes / upper abdominal pain / autistic disorder / cardiac dysrhythmia / rhabdomyolysis / seizure / Schizophrenia RISPERDAL / Orthostatic hypotension / pain / vomiting / blister / Tardive Dyskinesia A / Diabetes Mellitus / heart failure / Indication Initial Dose Schizophrenia / angioedema / dystonia / dizziness / Initial Dose Target Effective Dose Dose Range Schizophrenia / Tardive Dyskinesia / acute renal failure / syndrome / Chronic antipsychotic treatment / akathisia / / MedicalTreatment adjunctive therapy / drug therapy / / Organization Administration of RISPERDAL / Administration of RISPERDAL Oral / DOSAGE AND ADMINISTRATION / FDA / / / Position physician / / Product Disintegrating Tablets / RISPERDAL / Orally Disintegrating Tablet / Carbamazepine / risperidone / rifampin / Fluoxetine / phenytoin / Disintegrating Tablet / Neuroleptic Malignant Syndrome Antipsychotic / furosemide / M-TAB® Orally Disintegrating Tablets / Concomitant Medication / RISPERDAL® / including RISPERDAL / / Technology Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RISPERDAL® safely and effectively. See full prescribing information for RISPERDAL®. RISPERDAL® (risperidone) tabl